| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Jarvik ME |
Mechanism of action of lysergic acid diethylamide, serotonin, and rela... |
American Association... |
1956 |
| Cerletti A |
Lysergic acid diethylamide (LSD) and related compounds. (Psychopharma... |
Josiah Macy Jr. Foun... |
1956 |
| Rinaldi F |
The experimental electroencephalographic approach to psychopharmacolog... |
Psychiatr. Res. Rep. |
1956 |
| Rubin LS |
The psychopharmacology of lysergic acid diethylamide (LSD-25) |
Psychol. Bull. Wash. |
1957 |
| TRUITT EB, CALLAWAY E, BR... |
The pharmacology of myristicin: a contribution to the psychopharmacolo... |
J Neuropsychiatr |
1961 |
| Bradley P |
Hallucinogenic drugs. Psychopharmacology. |
Lancet |
1961 |
| M Hayman |
Science, Mysticism and Psychopharmacology |
California Med. |
1964 |
| Kline NS, Lehmann HE |
Psychopharmacology |
International Psychi... |
1965 |
| Krus DM, Resnick O, Raski... |
Apparent Eye Level Test; Its Background and Use in Psychopharmacology |
Arch. Gen. Psychiat. |
1966 |
| Daniel X. Freedman |
Aspects of the Biochemical Pharmacology of Psychotropic Drugs |
Psychedelic Review |
1966 |
| Shulgin AT, Sargent T, Na... |
The chemistry and psychopharmacology of nutmeg and of several related ... |
Psychopharmacol Bull |
1967 |
| Freedman DX |
The psychopharmacology of hallucinogenic agents |
Ann. Rev. Med. |
1969 |
| Grof S |
LSD and the Cosmic Game: Outline of Psychedelic Cosmology and Ontology |
Journal for the Stud... |
1972 |
| Klerman GL |
Psychotropic hedonism vs pharmacological Calvinism |
Hastings Cent Rep |
1972 |
| Itil TM, Saletu B, Akpina... |
Classification of Psychotropic Drugs Based on Digital Computer Sleep P... |
Mod.Probl.Pharmacops... |
1974 |
| Koshino, Yoshifumi; Otsuk... |
Psychotropic drugs and electroencephalography: third report |
Clinical Electroence... |
1974 |
| Green |
The Psychopharmacology of hallucinogens. |
Papers of a conferen... |
1976 |
| Sietnieks A, Meyerson BJ |
The Influence Of Progesterone On The Inhibitory Effect Of Lysergic Aci... |
Acta Pharmacologica ... |
1977 |
| Díaz JL |
Ethnopharmacology of sacred psychoactive plants used by the Indians of... |
Annu Rev Pharmacol T... |
1977 |
| Schlemmer RF, Tyler CB, N... |
The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social A... |
Federation Proceedin... |
1978 |
| Kemali M, Kemali D |
Observations On Central Nervous System Structures Following The Admini... |
Acta Neurol. |
1979 |
| de Montigny C, Blier P, C... |
Electrophysiologically-identified Serotonin Receptors In The Rat CNS |
Neuropharmacology |
1984 |
| Nichols DE |
Differences between the mechanism of action of MDMA, MBDB, and the cla... |
J Psychoactive Drugs |
1986 |
| Nichols DE, Hoffman AJ, O... |
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives ... |
J Med Chem |
1986 |
| Tsarong TJ |
Tibetan Psychopharmacology |
Integration |
1991 |
| Axt KJ, Mamounas LA, Moll... |
Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... |
Academic Press San D... |
1994 |
| Strassman RJ |
Hallucinogenic drugs in psychiatric research and treatment. Perspectiv... |
J Nerv Ment Dis |
1995 |
| Grob CS, McKenna DJ, Call... |
Human psychopharmacology of hoasca, a plant hallucinogen used in ritua... |
J Nerv Ment Dis |
1996 |
| Dulawa SC, Geyer MA |
Psychopharmacology of prepulse inhibition in mice |
Chin J Physiol |
1996 |
| McKenna DJ |
Plant hallucinogens: springboards for psychotherapeutic drug discovery |
Behav Brain Res |
1996 |
| Abraham HD, Aldridge AM, ... |
The Psychopharmacology of Hallucinogens |
Neuropsychopharmacol... |
1996 |
| Strassman RJ |
Human psychopharmacology of N,N-dimethyltryptamine |
Behav Brain Res |
1996 |
| Perrine DM |
Hallucinogens and Obsessive-Compulsive Disorder |
Am J Psychiatry |
1999 |
| Gamma A, Buck A, Berthold... |
Erratum. 3, 4-methylenedioxymeth-amphetamine (MDMA) modulates cortical... |
Neuropsychopharmacol... |
2000 |
| Gold MS, Tabrah H, Frost-... |
Psychopharmacology of MDMA (Ecstasy) |
Psychiatric Annals |
2001 |
| Aghajanian GK, Liebermann... |
Caveat Emptor: Editors Beware |
Neuropsychopharmacol... |
2001 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Perrine DM |
Visions of the Night: Western Medicine Meets Peyote 1887-1899 |
Heffter Review of Ps... |
2001 |
| Atkinson AJ, Sjoqvist F |
Bo Holmstedt, 1919-2002 |
Neuropsychopharmacol... |
2002 |
| Umbricht D, Vollenweider ... |
Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... |
Neuropsychopharmacol... |
2002 |
| McGregor IS, Clemens KJ, ... |
Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in... |
Neuropsychopharmacol... |
2003 |
| Sumnall HR, Jerome L, Dob... |
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, ... |
Psychopharmacology (... |
2003 |
| Sumnall HR, Jerome L, Dob... |
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, ... |
Psychopharmacology (... |
2004 |
| Fantegrossi WE, Woolverto... |
Behavioral and Neurochemical Consequences of Long-Term Intravenous Sel... |
Neuropsychopharmacol... |
2004 |
| Freudenmann RW, Spitzer M |
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-eth... |
CNS Drug Rev |
2004 |
| de Win MM, Habraken JB, R... |
Validation of [(123)I]beta-CIT SPECT to Assess Serotonin Transporters ... |
Neuropsychopharmacol... |
2005 |
| Carter OL, Pettigrew JD, ... |
Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations... |
Neuropsychopharmacol... |
2005 |
| Ersche KD, Roiser JP, Cla... |
Punishment Induces Risky Decision-Making in Methadone-Maintained Opiat... |
Neuropsychopharmacol... |
2005 |
| Mechan A, Yuan J, Hatzidi... |
Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in S... |
Neuropsychopharmacol... |
2005 |
| Ramaekers JG, Kuypers KP |
Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behaviora... |
Neuropsychopharmacol... |
2005 |
| McCann UD, Szabo Z, Secki... |
Quantitative PET Studies of the Serotonin Transporter in MDMA Users an... |
Neuropsychopharmacol... |
2005 |
| Gresch PJ, Smith RL, Barr... |
Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with ... |
Neuropsychopharmacol... |
2005 |
| Lambe EK, Aghajanian GK |
Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... |
Neuropsychopharmacol... |
2005 |
| Prisinzano TE |
Psychopharmacology of the hallucinogenic sage Salvia divinorum |
Life Sci |
2005 |
| Kenny PJ, Markou A |
Nicotine self-administration acutely activates brain reward systems an... |
Neuropsychopharmacol... |
2006 |
| Ellgren M, Spano SM, Hurd... |
Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Ne... |
Neuropsychopharmacol... |
2006 |
| Nichols DE |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| de Win MM, Reneman L, Jag... |
A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Us... |
Neuropsychopharmacol... |
2006 |
| Carter LP, Richards BD, M... |
Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor... |
Neuropsychopharmacol... |
2006 |
| Jager G, de Win MM, van d... |
Assessment of Cognitive Brain Function in Ecstasy Users and Contributi... |
Neuropsychopharmacol... |
2007 |
| Haney M |
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... |
Neuropsychopharmacol... |
2007 |
| Nichols DE, Frescas SP, C... |
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimetho... |
Bioorg Med Chem |
2008 |
| Passie T, Halpern JH, Sti... |
The pharmacology of lysergic Acid diethylamide: a review |
CNS Neurosci Ther |
2008 |
| Bossong MG, van Berckel B... |
Delta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Stri... |
Neuropsychopharmacol... |
2008 |
| Johnson MW, Maclean KA, R... |
Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... |
Drug Alcohol Depend |
2010 |
| Mithoefer MC, Wagner MT, ... |
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assi... |
J Psychopharmacol |
2011 |
| Addy PH |
Acute and post-acute behavioral and psychological effects of salvinori... |
Psychopharmacology (... |
2011 |
| Hart CL, Marvin CB, Silve... |
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical... |
Neuropsychopharmacol... |
2011 |
| Gatch MB, Gonzalez Maeso ... |
The HIV antiretroviral drug efavirenz has LSD-like properties |
Neuropsychopharmacol... |
2013 |
| Zanos P, Georgiou P, Wrig... |
The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Str... |
Neuropsychopharmacol... |
2013 |
| Kirkpatrick MG, Lee R, Wa... |
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Proces... |
Neuropsychopharmacol... |
2014 |
| Halberstadt AL |
Recent advances in the neuropsychopharmacology of serotonergic halluci... |
Behav Brain Res |
2015 |
| Bosch OG, Seifritz E |
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone ... |
Brain Res Bull |
2016 |
| Papaseit E, Pérez-Mañá C,... |
Human Pharmacology of Mephedrone in Comparison to MDMA |
Neuropsychopharmacol... |
2016 |
| Hartogsohn I |
Set and setting, psychedelics and the placebo response: An extra-pharm... |
J Psychopharmacol |
2016 |
| Heifets BD, Malenka RC |
Disruptive Psychopharmacology |
JAMA Psychiatry |
2019 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
